Northwestern Mutual Wealth Management’s Vir Biotechnology VIR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$510	Buy	+50	New	+$476	﹤0.01%	3880
2024 Q2	–	Sell	-5	Closed	-$51	–	3838
2024 Q1	$51	Buy	+5	New	+$51	﹤0.01%	3469
2023 Q2	–	Sell	-51	Closed	-$1.19K	–	3629
2023 Q1	$1.19K	Buy	+51	New	+$1.3K	﹤0.01%	3001
2022 Q3	–	Sell	-7	Closed	–	–	3421
2022 Q2	$0	Hold	7	–	–	﹤0.01%	3496
2022 Q1	$0	Buy	+7	New	+$208	﹤0.01%	3421

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northwestern Mutual Wealth Management's VIR Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Vir Biotechnology (VIR) in Q2 2026: 50 shares worth $510. The stake represents ﹤0.01% of the portfolio and ranks #3880 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in VIR as recently as Q1 2024.

Northwestern Mutual Wealth Management first reported a position in VIR in Q1 2022 and has held it in 5 quarters since. The position peaked at $1.19K in Q1 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Northwestern Mutual Wealth Management held 50 shares of Vir Biotechnology worth $510 as of Q2 2026.
Vir Biotechnology was a new Northwestern Mutual Wealth Management position in Q2 2026.
Vir Biotechnology made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3880 holding.
Northwestern Mutual Wealth Management first reported a position in Vir Biotechnology in Q1 2022 and has held it in 5 quarters since.
Northwestern Mutual Wealth Management's Vir Biotechnology position peaked at $1.19K in Q1 2023.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.